Articles

The addition of insulin to the treatment regimen of type 2 diabetes patients on liraglutide (Victoza) doesn’t wipe out previously seen weight loss, and insulin also appears to help these patients achieve glycemic control, researchers said.…

International guidelines on screening for gestational diabetes that will raise the prevalence of the condition have sparked questions over appropriate diagnostic tools and cost efficacy, researchers said.…

Hoffmann-LaRoche and the JDRF have discovered not only a protein that regulates beta cell growth, but also a chemical compound that stimulates it.…

According to a new study, people with diabetes appear to be at a significantly increased risk of developing dementia and the study also found that risk of developing dementia significantly increased for those with pre-diabetes.…

Compared with resistance training, aerobic exercise burns 67% more calories, research shows.…

Collectively, lifestyle factors, including not smoking, regular physical activity, healthy diet, moderate alcohol consumption, and normal body weight, are associated with a substantially decreased risk of developing diabetes, according to new research findings.…

Adding the type 2 diabetes drug liraglutide (Victoza) to insulin therapy improves glycemic control in patients with type 1 disease, researchers said….

Being obese might up the chance of developing Type 2 diabetes, but the true risk factors may lie in how much someone is overweight and how long they’ve been that way. This is crucial information because we are seeing more obesity in young children….

In newly diagnosed type 2 diabetes, therapy with oral antidiabetes drugs plus basal insulin (OAD+insulin) has had favorable outcomes on recovery and maintenance of β-cell function and protracted glycemic remission compared to treatment with OAD alone….

Use of electronic health records (EHRs) for patients with diabetes improves achievement of care and outcomes targets, researchers found.…